These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 26518543)

  • 21. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-myc overexpression causes anaplasia in medulloblastoma.
    Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
    Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
    Zindy F; Uziel T; Ayrault O; Calabrese C; Valentine M; Rehg JE; Gilbertson RJ; Sherr CJ; Roussel MF
    Cancer Res; 2007 Mar; 67(6):2676-84. PubMed ID: 17363588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
    Diaz RJ; Golbourn B; Faria C; Picard D; Shih D; Raynaud D; Leadly M; MacKenzie D; Bryant M; Bebenek M; Smith CA; Taylor MD; Huang A; Rutka JT
    Oncotarget; 2015 Feb; 6(5):3359-74. PubMed ID: 25739120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2.
    Shakhova O; Leung C; van Montfort E; Berns A; Marino S
    Cancer Res; 2006 May; 66(10):5190-200. PubMed ID: 16707443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
    Hill RM; Kuijper S; Lindsey JC; Petrie K; Schwalbe EC; Barker K; Boult JK; Williamson D; Ahmad Z; Hallsworth A; Ryan SL; Poon E; Robinson SP; Ruddle R; Raynaud FI; Howell L; Kwok C; Joshi A; Nicholson SL; Crosier S; Ellison DW; Wharton SB; Robson K; Michalski A; Hargrave D; Jacques TS; Pizer B; Bailey S; Swartling FJ; Weiss WA; Chesler L; Clifford SC
    Cancer Cell; 2015 Jan; 27(1):72-84. PubMed ID: 25533335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma.
    Frank AJ; Hernan R; Hollander A; Lindsey JC; Lusher ME; Fuller CE; Clifford SC; Gilbertson RJ
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):137-40. PubMed ID: 14969745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
    Korshunov A; Remke M; Werft W; Benner A; Ryzhova M; Witt H; Sturm D; Wittmann A; Schöttler A; Felsberg J; Reifenberger G; Rutkowski S; Scheurlen W; Kulozik AE; von Deimling A; Lichter P; Pfister SM
    J Clin Oncol; 2010 Jun; 28(18):3054-60. PubMed ID: 20479417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.
    Brown HG; Kepner JL; Perlman EJ; Friedman HS; Strother DR; Duffner PK; Kun LE; Goldthwaite PT; Burger PC
    J Neuropathol Exp Neurol; 2000 Oct; 59(10):857-65. PubMed ID: 11079775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.
    Li Y; Guessous F; Johnson EB; Eberhart CG; Li XN; Shu Q; Fan S; Lal B; Laterra J; Schiff D; Abounader R
    Lab Invest; 2008 Feb; 88(2):98-111. PubMed ID: 18059365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
    Garcia I; Crowther AJ; Gama V; Miller CR; Deshmukh M; Gershon TR
    Oncogene; 2013 May; 32(18):2304-14. PubMed ID: 22710714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation.
    Behesti H; Bhagat H; Dubuc AM; Taylor MD; Marino S
    Dis Model Mech; 2013 Jan; 6(1):49-63. PubMed ID: 23065639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
    Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
    Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.
    Ellison DW; Kocak M; Dalton J; Megahed H; Lusher ME; Ryan SL; Zhao W; Nicholson SL; Taylor RE; Bailey S; Clifford SC
    J Clin Oncol; 2011 Apr; 29(11):1400-7. PubMed ID: 20921458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.
    Su X; Gopalakrishnan V; Stearns D; Aldape K; Lang FF; Fuller G; Snyder E; Eberhart CG; Majumder S
    Mol Cell Biol; 2006 Mar; 26(5):1666-78. PubMed ID: 16478988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup Medulloblastomas.
    Grausam KB; Dooyema SDR; Bihannic L; Premathilake H; Morrissy AS; Forget A; Schaefer AM; Gundelach JH; Macura S; Maher DM; Wang X; Heglin AH; Ge X; Zeng E; Puget S; Chandrasekar I; Surendran K; Bram RJ; Schüller U; Talyor MD; Ayrault O; Zhao H
    Cancer Res; 2017 Jul; 77(14):3766-3777. PubMed ID: 28490517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
    Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
    Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN Signaling in the Postnatal Perivascular Progenitor Niche Drives Medulloblastoma Formation.
    Zhu G; Rankin SL; Larson JD; Zhu X; Chow LM; Qu C; Zhang J; Ellison DW; Baker SJ
    Cancer Res; 2017 Jan; 77(1):123-133. PubMed ID: 27815386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
    Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
    Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma.
    Chaturvedi NK; Kling MJ; Griggs CN; Kesherwani V; Shukla M; McIntyre EM; Ray S; Liu Y; McGuire TR; Sharp JG; Band H; Joshi SS; Coulter DW
    Mol Cancer Ther; 2020 Jun; 19(6):1351-1362. PubMed ID: 32371591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.